Ticker > Company >

Arvaya Healthcare share price

Arvaya Healthcare Ltd.

BSE: 524723 SECTOR: Trading  5.63 K   1   0

57.99
+2.76 (5.00%)
BSE: 11 May 4:00 PM

Price Summary

Today's High

₹ 57.99

Today's Low

₹ 57.99

52 Week High

₹ 57.99

52 Week Low

₹ 24.15

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

278.48 Cr.

Enterprise Value

275.77 Cr.

No. of Shares

4.8 Cr.

P/E

0

P/B

4.71

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  12.3

CASH

2.71 Cr.

DEBT

0 Cr.

Promoter Holding

30.62 %

EPS (TTM)

₹  -0.19

Sales Growth

-0.33%

ROE

3.93 %

ROCE

5.74%

Profit Growth

216.13 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-0.33%
3 Year-5.13%
5 Year-10.74%

Profit Growth

1 Year216.13%
3 Year39.63%
5 Year35.25%

ROE%

1 Year3.93%
3 Year-3.79%
5 Year-3.63%

ROCE %

1 Year5.74%
3 Year-3%
5 Year-3.12%

Debt/Equity

0

Price to Cash Flow

1290.17

Interest Cover Ratio

20.8654

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 30.62 0.00
Dec 2025 62.73 0.00
Sep 2025 62.73 0.00
Jun 2025 63.10 0.00
Mar 2025 7.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 0.0605781 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Company has a healthy liquidity position with current ratio of 48.3642.

 Limitations

  • The company has shown a poor revenue growth of -5.12976277634659% for the Past 3 years.
  • Company has a poor ROE of -3.78846666666667% over the past 3 years.
  • Company has a poor ROCE of -3.0032% over the past 3 years
  • The company has a low EBITDA margin of -129.881941132326% over the past 5 years.
  • Promoter stake has been decreased from 62.73% to 30.62%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 0.13 0 0 0 0
Total Expenditure 0.2 0.19 0.29 0.33 0.21
Operating Profit -0.07 -0.19 -0.29 -0.33 -0.21
Other Income 0.05 0.05 0.03 0.02 0.05
Interest 0 0.01 0 0 0
Depreciation 0.01 0 0 0 0
Exceptional Items 0.56 0 0 0 0
Profit Before Tax 0.53 -0.15 -0.25 -0.31 -0.16
Tax 0 0.06 0 0 0
Profit After Tax 0.53 -0.21 -0.25 -0.31 -0.16
Adjusted EPS (Rs) 1.78 -0.68 -0.34 -0.41 -0.22

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0.4 0.33 0.3 0.28 0.28
Total Expenditure 0.66 0.63 0.82 0.65 0.8
Operating Profit -0.26 -0.3 -0.52 -0.37 -0.52
Other Income 0.21 0.15 0.14 0.3 0.19
Interest 0 0 0.01 0.01 0.01
Depreciation 0.04 0.03 0.06 0.05 0.02
Exceptional Items 0 0 0 0 0.56
Profit Before Tax -0.09 -0.19 -0.44 -0.12 0.19
Tax 0 0 0 0 0.05
Net Profit -0.09 -0.19 -0.44 -0.12 0.14
Adjusted EPS (Rs.) -0.3 -0.63 -1.48 -0.39 0.45

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 3 3 3 3 3
Total Reserves 1.14 0.95 0.51 0.39 0.53
Borrowings 0 0 0 0 0
Other N/C liabilities -0.03 -0.03 -0.03 -0.03 0
Current liabilities 0.03 0.04 0.12 0.1 0.06
Total Liabilities 4.15 3.96 3.6 3.46 3.59
Assets
Net Block 0.74 0.71 0.76 0.4 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.05 0.14 0.2 0.38 0.13
Loans & Advances 0.51 0.22 0.67 0.67 0.37
Other N/C Assets 0.05 0.09 0.13 0.16 0.11
Current Assets 2.79 2.8 1.83 1.85 2.98
Total Assets 4.15 3.96 3.6 3.46 3.59
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -0.09 -0.19 -0.44 -0.12 0.19
Adjustment 0.04 0.03 0.06 0.05 -0.53
Changes in Assets & Liabilities 0.03 -0.21 0.13 -0.22 0.58
Tax Paid 0 0 0 0 -0.03
Operating Cash Flow -0.01 -0.37 -0.26 -0.29 0.22
Investing Cash Flow 0 0 -0.11 0.32 0.92
Financing Cash Flow 0 0 0.08 -0.02 -0.06
Net Cash Flow -0.02 -0.37 -0.29 0.01 1.08

Corporate Actions

Investors Details

PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
promoters 7.74 63.10 62.73 62.73 30.62
agri one india ventures l... - 24.40 25.06 25.06 3.91
kaushal uttam shah - - - 11.71 1.83
shantanu jagannath surpur... - - 0.91 0.91 0.14
smcv management services ... - - - - 20.82
u.g.patwardhan services p... - - 25.06 25.06 3.91
kaushal shah - 11.20 11.71 - -
ashimkumar patawari - 0.85 - - -
ashok kumar patawari 4.61 1.84 - - -
shweta patawari 0.10 0.04 - - -
sushila devi patawari 0.92 0.37 - - -
u g patwardhan services p... - 24.40 - - -
ashim kumar patawari 2.12 - - - -
PARTICULARS Sep 2025% Dec 2025% Mar 2026%
investors 37.27 37.27 69.38
arogya tech services llp - - 6.82
bidari kotresh anilkumar - - 3.58
dattatraya dasharathrao j... - - 3.63
llp 0.01 0.01 7.24
manojkumar vaijanathrao b... - - 3.07
muralidhar r doddamani - - 3.53
praveenkumar fakeeragouda... - - 3.53
shambhu k - - 3.63
sharat mohan vijapur - - 3.63
shrinivas shamsundar tosh... - - 1.04
shyam shashikant bhairi - - 3.63
srishail chiniwalar - - 3.63

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Bijoy Hans submits voting results and scrutinizer’s report 21 Apr, 4:35 PM Bijoy Hans informs about board meeting 7 Mar, 10:52 AM Bijoy Hans submits voting results and scrutinizer’s report 26 Feb, 5:02 PM Bijoy Hans informs about receipt of request for reclassification 24 Feb, 5:16 PM Bijoy Hans inks pact to acquire 100% stake in Tec-Pool Solutions 8 Nov, 11:34 AM Bijoy Hans informs about press release 6 Nov, 4:36 PM Bijoy Hans informs about disclosure 22 Aug, 5:17 PM Bijoy Hans informs about disclosure 18 Aug, 12:45 PM Bijoy Hans informs about disclosure 13 Aug, 11:21 AM Bijoy Hans informs about disclosure 12 Aug, 1:17 PM Bijoy Hans informs about disclosure 11 Aug, 5:30 PM Bijoy Hans informs about disclosure 11 Aug, 11:11 AM Bijoy Hans informs about disclosure 8 Aug, 5:28 PM Bijoy Hans informs about book closure 28 Jul, 5:09 PM Bijoy Hans informs about statement of deviations or variations 28 Jul, 4:55 PM Bijoy Hans - Quaterly Results 28 Jul, 3:16 PM Bijoy Hans - Quaterly Results 28 Jul, 3:16 PM Bijoy Hans - Quaterly Results 28 Jul, 3:16 PM Bijoy Hans informs about open offer 12 Jun, 2:32 PM Bijoy Hans informs about outcome of board meeting 26 May, 5:35 PM Bijoy Hans - Quaterly Results 26 May, 4:53 PM Bijoy Hans - Quaterly Results 26 May, 4:53 PM Bijoy Hans - Quaterly Results 26 May, 4:53 PM Bijoy Hans - Quaterly Results 4 Feb, 4:24 PM Bijoy Hans - Quaterly Results 4 Feb, 4:24 PM Bijoy Hans - Quaterly Results 4 Feb, 4:24 PM Bijoy Hans informs about non-applicability certificate 15 Jan, 4:55 PM Bijoy Hans informs about corrigendum to notice of EGM 10 Jan, 5:37 PM Bijoy Hans informs about outcome of board meeting 7 Jan, 5:04 PM Bijoy Hans informs about outcome of board meeting 21 Dec, 4:39 PM Bijoy Hans - Quaterly Results 9 Nov, 4:06 PM Bijoy Hans - Quaterly Results 9 Nov, 4:06 PM Bijoy Hans - Quaterly Results 9 Nov, 4:06 PM Bijoy Hans informs about disclosure 25 Sep, 3:09 PM Bijoy Hans informs about AGM and annual report 23 Aug, 12:31 PM Bijoy Hans informs about AGM 23 Aug, 11:19 AM Bijoy Hans - Quaterly Results 13 Aug, 4:38 PM Bijoy Hans - Quaterly Results 13 Aug, 4:38 PM Bijoy Hans - Quaterly Results 12 Feb, 3:53 PM Bijoy Hans - Quaterly Results 12 Feb, 3:53 PM Bijoy Hans - Quaterly Results 12 Feb, 3:53 PM Bijoy Hans informs about book closure 26 Aug, 3:04 PM Bijoy Hans - Quaterly Results 14 Aug, 3:52 PM Bijoy Hans informs about delay in financial results 3 Jun, 3:50 PM Bijoy Hans - Quaterly Results 1 Feb, 3:31 PM Bijoy Hans - Quaterly Results 1 Feb, 3:31 PM Bijoy Hans - Quaterly Results 1 Feb, 3:31 PM Bijoy Hans - Quaterly Results 3 Aug, 3:54 PM Bijoy Hans - Quaterly Results 3 Aug, 3:54 PM Bijoy Hans - Quaterly Results 3 Aug, 3:54 PM

Arvaya Healthcare Stock Price Analysis and Quick Research Report. Is Arvaya Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Arvaya Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Arvaya Healthcare has a PE ratio of -299.68992248062 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Arvaya Healthcare has ROA of 3.8594% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Arvaya Healthcare has a Current ratio of 48.3642.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Arvaya Healthcare has a ROE of 3.9343%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Arvaya Healthcare has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Arvaya Healthcare has reported revenue growth of -0.3275% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Arvaya Healthcare for the current financial year is -187.665503352818%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Arvaya Healthcare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Arvaya Healthcare is Rs -0.1935. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Arvaya Healthcare in Ticker for free. Also, one can get the intrinsic value of Arvaya Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Arvaya Healthcare FAQs

Q1. What is Arvaya Healthcare share price today?
Ans: The current share price of Arvaya Healthcare is Rs 57.99.

Q2. What is the market capitalisation of Arvaya Healthcare?
Ans: Arvaya Healthcare has a market capitalisation of Rs 278.478748743 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Arvaya Healthcare?
Ans: The PE ratio of Arvaya Healthcare is -299.68992248062 and the P/B ratio of Arvaya Healthcare is 4.71363776762636, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Arvaya Healthcare share?
Ans: The 52-week high share price of Arvaya Healthcare is Rs 57.99, and the 52-week low share price of Arvaya Healthcare is Rs 24.15.

Q5. Does Arvaya Healthcare pay dividends?
Ans: Currently, Arvaya Healthcare does not pay dividends. Dividend yield of Arvaya Healthcare is around 0%.

Q6. What are the face value and book value of Arvaya Healthcare shares?
Ans: The face value of Arvaya Healthcare shares is Rs 10, while the book value per share of Arvaya Healthcare is around Rs 12.3026. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Arvaya Healthcare?
Ans: Arvaya Healthcare has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Arvaya Healthcare?
Ans: The ROE of Arvaya Healthcare is 3.9343% and ROCE of Arvaya Healthcare is 5.744%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Arvaya Healthcare a good buy for the long term?
Ans: The Arvaya Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Arvaya Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Arvaya Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Arvaya Healthcare’s financials?
Ans: You can review Arvaya Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Arvaya Healthcare
X